252 related articles for article (PubMed ID: 37681099)
1. A short review on the applicability and use of cubosomes as nanocarriers.
Palma AS; Casadei BR; Lotierzo MC; de Castro RD; Barbosa LRS
Biophys Rev; 2023 Aug; 15(4):553-567. PubMed ID: 37681099
[TBL] [Abstract][Full Text] [Related]
2. A Versatile Nanocarrier-Cubosomes, Characterization, and Applications.
Oliveira C; Ferreira CJO; Sousa M; Paris JL; Gaspar R; Silva BFB; Teixeira JA; Ferreira-Santos P; Botelho CM
Nanomaterials (Basel); 2022 Jun; 12(13):. PubMed ID: 35808060
[TBL] [Abstract][Full Text] [Related]
3. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
[TBL] [Abstract][Full Text] [Related]
4. Cubic-to-inverted micellar and the cubic-to-hexagonal-to-micellar transitions on phytantriol-based cubosomes induced by solvents.
Lotierzo MCG; Casadei BR; de Castro RD; Malheiros B; Barbosa LRS
Drug Deliv Transl Res; 2020 Dec; 10(6):1571-1583. PubMed ID: 32783155
[TBL] [Abstract][Full Text] [Related]
5. Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood-brain barrier.
Azhari H; Strauss M; Hook S; Boyd BJ; Rizwan SB
Eur J Pharm Biopharm; 2016 Jul; 104():148-55. PubMed ID: 27163239
[TBL] [Abstract][Full Text] [Related]
6. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
[TBL] [Abstract][Full Text] [Related]
7. Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.
A Vahab S; Nair A; Raj D; G P A; P P S; S Kumar V
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3729-3746. PubMed ID: 38095651
[TBL] [Abstract][Full Text] [Related]
8. Polymer Cubosomes: Infinite Cubic Mazes and Possibilities.
Ha S; La Y; Kim KT
Acc Chem Res; 2020 Mar; 53(3):620-631. PubMed ID: 31920073
[TBL] [Abstract][Full Text] [Related]
9. Cubosomes in Drug Delivery-A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications.
Sivadasan D; Sultan MH; Alqahtani SS; Javed S
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189732
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
Micron; 2007; 38(5):478-85. PubMed ID: 17011783
[TBL] [Abstract][Full Text] [Related]
11. The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics.
Gowda BHJ; Ahmed MG; Alshehri SA; Wahab S; Vora LK; Singh Thakur RR; Kesharwani P
Environ Res; 2023 Nov; 237(Pt 1):116894. PubMed ID: 37586450
[TBL] [Abstract][Full Text] [Related]
12. Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds.
Tan C; Hosseini SF; Jafari SM
J Agric Food Chem; 2022 Feb; 70(5):1423-1437. PubMed ID: 35089018
[TBL] [Abstract][Full Text] [Related]
13. Lipid membranes exposed to dispersions of phytantriol and monoolein cubosomes: Langmuir monolayer and HeLa cell membrane studies.
Jabłonowska E; Matyszewska D; Nazaruk E; Godlewska M; Gaweł D; Bilewicz R
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129738. PubMed ID: 32956751
[TBL] [Abstract][Full Text] [Related]
14. Cubosomes: an overview.
Garg G; Saraf S; Saraf S
Biol Pharm Bull; 2007 Feb; 30(2):350-3. PubMed ID: 17268078
[TBL] [Abstract][Full Text] [Related]
15. A Synoptic Update on Smart Lipid Nanocarrier: Cubosomes, and their Design Development, and Recent Challenges.
Sreelaya P; Bhattacharya S
Curr Pharm Biotechnol; 2024; 25(4):434-447. PubMed ID: 37211845
[TBL] [Abstract][Full Text] [Related]
16. Cubosomes: Versatile Nanosized Formulation for Efficient Delivery of Therapeutics.
Singhal K; Kaushik N; Kumar A
Curr Drug Deliv; 2022; 19(6):644-657. PubMed ID: 34238187
[TBL] [Abstract][Full Text] [Related]
17. Cubosomes: remarkable drug delivery potential.
Karami Z; Hamidi M
Drug Discov Today; 2016 May; 21(5):789-801. PubMed ID: 26780385
[TBL] [Abstract][Full Text] [Related]
18. Thermo-responsive lipophilic NIPAM-based block copolymers as stabilizers for lipid-based cubic nanoparticles.
Balestri A; Lonetti B; Harrisson S; Farias-Mancilla B; Zhang J; Amenitsch H; Schubert US; Guerrero-Sanchez C; Montis C; Berti D
Colloids Surf B Biointerfaces; 2022 Dec; 220():112884. PubMed ID: 36209550
[TBL] [Abstract][Full Text] [Related]
19. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
Singh S; Sachan K; Verma S; Singh N; Singh PK
Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs Using Monoolein Cubosomes.
Ali MA; Kataoka N; Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
Chem Pharm Bull (Tokyo); 2017; 65(1):42-48. PubMed ID: 28049915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
